CONCERT PHARMACEUTICALS, INC. (CNCE) has 52 open-market insider trades by 24 insiders since 2014. The most active filer is Richard Aldrich, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Biotechnology VALUE FUND L P | 10% Owner | — | 2 | $76.3M | 2019-06-10 |
| Wilfred E. Jaeger | Dir | — | 2 | $13.4M | 2023-03-06 |
| BVF Partners OS Ltd. | 10% Owner | — | 1 | $10.5M | 2017-10-19 |
| Arch Management Iii Llc Three | Dir | — | 3 | $6.7M | 2015-09-10 |
| Brookside Capital Partners FUND L.P. | 10% | — | 1 | $4.9M | 2014-02-19 |
| Richard Aldrich | Dir | — | 7 | $4.8M | 2023-03-06 |
| Arch Management Iv L.l.c. Three | Dir | — | 3 | $4.7M | 2015-08-13 |
| QVT Associates GP LLC | 10% | — | 1 | $4.2M | 2014-02-19 |
| Arch Associates Iv Lp Three | 10% | — | 1 | $3.1M | 2014-11-18 |
| John Gordon Freund | Dir10% | — | 1 | $2.1M | 2014-02-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Nancy Stuart | COO | Sell | $101K | 2023-02-15 |
| Marc A. Becker | CFO | Sell | $31K | 2023-02-15 |
| James V. Cassella | Chief Development Officer | Sell | $31K | 2023-02-15 |
| Nancy Stuart | COO | Sell | $110K | 2023-01-30 |
| Jeffrey A. Munsie | CLO | Sell | $142K | 2023-01-30 |
| James V. Cassella | — | Sell | $169K | 2023-01-30 |
Companies that share insiders with CNCE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Roger D. Tung | CEO | Sell | $134K | 2023-01-06 |
| Nancy Stuart | COO | Sell | $21K | 2023-01-06 |
| Peter Barton Hutt | Director | Sell | $22K | 2022-10-14 |
| Richard Aldrich | Director | Buy | $2.0M | 2022-06-06 |
| Christi van Heek | Director | Buy | $50K | 2022-06-06 |
| Thomas G. Auchincloss | Director | Buy | $29K | 2022-06-06 |
| Roger D. Tung | CEO | Sell | $42K | 2022-02-15 |
| Marc A. Becker | CFO | Sell | $12K | 2022-02-14 |
| James V. Cassella | Chief Development Officer | Sell | $12K | 2022-02-14 |